Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX
· Real-Time Price · USD
12.62
0.31 (2.52%)
At close: May 09, 2025, 10:45 AM
2.52% (1D)
Bid | 9.14 |
Market Cap | 494.27M |
Revenue (ttm) | 799.49M |
Net Income (ttm) | -126M |
EPS (ttm) | -3.3 |
PE Ratio (ttm) | -3.82 |
Forward PE | -17.73 |
Analyst | Buy |
Ask | 16.01 |
Volume | 185,849 |
Avg. Volume (20D) | 265,190 |
Open | 12.50 |
Previous Close | 12.31 |
Day's Range | 12.43 - 12.77 |
52-Week Range | 10.50 - 20.73 |
Beta | 0.88 |
About OFIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OFIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OFIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Orthofix Medical has released their quartely earnings
on May 6, 2025:
2 days ago
-10.93%
Orthofix Medical shares are trading lower after th...
Unlock content with
Pro Subscription
6 months ago
+6.53%
Orthofix Medical shares are trading higher after the company reported better-than-expected Q3 financial results and entered into a new-credit agreement worth up to $275 million. Additionally, Stifel upgraded the stock from Hold to Buy and raised its price target from $18 to $24 while Roth MKM raised its price target from $20 to $22.

1 month ago · businesswire.com
Orthofix Announces Appointment of Vickie Capps to Board of DirectorsLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the appointment of Vickie Capps to the Company's Board of Director...

2 months ago · businesswire.com
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal ConferenceLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Mu...